相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMPK Activation by Oncogenesis Is Required to Maintain Cancer Cell Proliferation in Astrocytic Tumors
Marcos Rios et al.
CANCER RESEARCH (2013)
Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells
Di Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Metformin in cancer: translational challenges
Ryan J. O. Dowling et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Activation of AMP-Activated Protein Kinase by 3,3′-Diindolylmethane (DIM) Is Associated with Human Prostate Cancer Cell Death In Vitro and In Vivo
Di Chen et al.
PLOS ONE (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells
Daniel E. Frigo et al.
CANCER RESEARCH (2011)
Androgen receptor and its splice variants in prostate cancer
Simon Haile et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
Jing Li et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Hormone Depletion-Insensitivity of Prostate Cancer Cells Is Supported by the AR Without Binding to Classical Response Elements
Mesfin Gonit et al.
MOLECULAR ENDOCRINOLOGY (2011)
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
S. Fogarty et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis
Nabil Djouder et al.
EMBO JOURNAL (2010)
Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
Q. Shi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells
Tao Pang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Calpain-Mediated Androgen Receptor Breakdown in Apoptotic Prostate Cancer Cells
Huanjie Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Androgen receptor and prostate cancer
E. Richter et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
Calmodulin-androgen receptor (AR) interaction: Calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells
Ronald P. Pelley et al.
CANCER RESEARCH (2006)
Non-genomic steroid hormone effects:: Membrane or intracellular receptors?
Martin Wehling et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro
Milica Momcilovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer
Hiroyuki Motoshima et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491
S Horman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase
SA Hawley et al.
CELL METABOLISM (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells
HK Lin et al.
MOLECULAR ENDOCRINOLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Overexpression of interleukin-2 receptor α in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability
DJ Kuhn et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels
L Sheflin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
PCF Cheung et al.
BIOCHEMICAL JOURNAL (2000)
The regulation of AMP-activated protein kinase by phosphorylation
SC Stein et al.
BIOCHEMICAL JOURNAL (2000)
分享论文
